Science Explorer Back to mapMap
Discussion
Company · Seattle · United States

Omeros Corporation (United States)

Research works
68
◆ 1% vs 2018-21
Citations
2.6k
38.5 per fractional work
Top-10% rate
8.3%
all institutions 10.0%
Open access
42%
world 40%
International
31%
world 18%

Not ranked overall: Omeros Corporation (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Omeros Corporation (United States) work in?

In all years, 52% of research at Omeros Corporation (United States) is in Life Sciences, 34% in Health Sciences. Its largest fields are Medicine (34%), Biochemistry, Genetics and Molecular Biology (26%), Immunology and Microbiology (20%). It does 2.9× the world's share of Life Sciences.

Life Sciences: 35 fractional works · 51.8% of its workBiochemistry, Genetics and Molecular Biology: 18 fractional works · 26.5% of its workMolecular Biology: 12 fractional works · 17.5% of its workBiophysics: 3 fractional works · 5.0% of its workPhysiology: 1 fractional works · 1.0% of its workGenetics: 1 fractional works · 0.9% of its workCancer Research: 1 fractional works · 0.8% of its workEndocrinology: 0 fractional works · 0.5% of its workBiotechnology: 0 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.4% of its workImmunology and Microbiology: 14 fractional works · 20.1% of its workImmunology: 13 fractional works · 19.7% of its workVirology: 0 fractional works · 0.4% of its workNeuroscience: 3 fractional works · 4.4% of its workCellular and Molecular Neuroscience: 2 fractional works · 2.7% of its workNeurology: 1 fractional works · 0.9% of its workBehavioral Neuroscience: 0 fractional works · 0.5% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.7% of its workPlant Science: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workHealth Sciences: 23 fractional works · 34.4% of its workMedicine: 23 fractional works · 33.8% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 3.5% of its workSurgery: 2 fractional works · 2.8% of its workOphthalmology: 2 fractional works · 2.5% of its workNephrology: 2 fractional works · 2.4% of its workGenetics: 2 fractional works · 2.3% of its workPharmacology: 2 fractional works · 2.2% of its workEpidemiology: 1 fractional works · 2.1% of its workHematology: 1 fractional works · 2.0% of its workPhysiology: 1 fractional works · 1.8% of its workInfectious Diseases: 1 fractional works · 1.7% of its workOncology: 1 fractional works · 1.5% of its workRheumatology: 1 fractional works · 1.2% of its workDermatology: 1 fractional works · 1.0% of its workReproductive Medicine: 1 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.9% of its workTransplantation: 1 fractional works · 0.9% of its workPathology and Forensic Medicine: 1 fractional works · 0.8% of its workUrology: 0 fractional works · 0.6% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workBiochemistry: 0 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workNursing: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.5% of its workHealth Professions: 0 fractional works · 0.2% of its workPhysical Sciences: 7 fractional works · 10.3% of its workEngineering: 4 fractional works · 5.2% of its workBiomedical Engineering: 2 fractional works · 2.3% of its workOcean Engineering: 1 fractional works · 1.5% of its workCivil and Structural Engineering: 0 fractional works · 0.5% of its workComputational Mechanics: 0 fractional works · 0.5% of its workMechanical Engineering: 0 fractional works · 0.5% of its workPhysics and Astronomy: 1 fractional works · 1.2% of its workAtomic and Molecular Physics, and Optics: 1 fractional works · 1.0% of its workAcoustics and Ultrasonics: 0 fractional works · 0.3% of its workComputer Science: 1 fractional works · 1.1% of its workComputational Theory and Mathematics: 0 fractional works · 0.7% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 1 fractional works · 1.0% of its workBiomaterials: 1 fractional works · 1.0% of its workChemistry: 1 fractional works · 0.9% of its workOrganic Chemistry: 1 fractional works · 0.9% of its workEnvironmental Science: 0 fractional works · 0.7% of its workEcological Modeling: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.2% of its workSocial Sciences: 2 fractional works · 3.5% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.0% of its workEconomics and Econometrics: 0 fractional works · 0.7% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 0.3% of its workDecision Sciences: 1 fractional works · 0.8% of its workManagement Science and Operations Research: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.0% of its workBusiness, Management and Accounting: 0 fractional works · 0.7% of its workMarketing: 0 fractional works · 0.3% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.3% of its workStrategy and Management: 0 fractional works · 0.3% of its workPsychology: 0 fractional works · 0.7% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.3% of its workClinical Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.3% of its workGender Studies: 0 fractional works · 0.3% of its workArts and Humanities: 0 fractional works · 0.0% of its workALL ITS WORKOmerosCorporation…68fractional works, all years
Life Sciences52%Physical Sciences10%Health Sciences34%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1826.5%
    2. Immunology and Microbiology1420.1%
    3. Neuroscience34.4%
    4. Agricultural and Biological Sciences00.7%
    5. Pharmacology, Toxicology and Pharmaceutics00.1%
    1. Medicine2333.8%
    2. Nursing00.5%
    3. Health Professions00.2%
    1. Engineering45.2%
    2. Physics and Astronomy11.2%
    3. Computer Science11.1%
    4. Materials Science11.0%
    5. Chemistry10.9%
    6. Environmental Science00.7%
    7. Energy00.2%
    1. Economics, Econometrics and Finance11.0%
    2. Decision Sciences10.8%
    3. Business, Management and Accounting00.7%
    4. Psychology00.7%
    5. Social Sciences00.3%
    6. Arts and Humanities00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.97× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 22.11× its world share, 2 worksImmunology and Micro…Neuroscience: 1.04× its world share, 0 worksNeuroscienceHealth Professions: 0.45× its world share, 0 worksHealth ProfessionsMedicine: 3.14× its world share, 6 worksMedicineArts and Humanities: 0.07× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 1.10× its world share, 0 worksBusiness, Management…Decision Sciences: 0.22× its world share, 0 worksDecision Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 22.1×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Immunology and Microbiology22.11×2 works
  2. Medicine3.14×6 works
  3. Biochemistry, Genetics and Molecular Biology1.97×1 works
  4. Business, Management and Accounting1.10×0 works
  5. Neuroscience1.04×0 works
  6. Health Professions0.45×0 works
  7. Decision Sciences0.22×0 works
  8. Arts and Humanities0.07×0 works

Who are the top researchers at Omeros Corporation (United States)?

Ranked on the quality score, Steve Whitaker, George Gaitanaris and Thomas Dudler lead among researchers whose main affiliation is Omeros Corporation (United States).

  1. 1 Steve Whitaker United States · #574,094 worldwide 1.7k citations · 22 works
  2. 2 George Gaitanaris United States · #723,795 worldwide 3k citations · 38 works
  3. 3 Thomas Dudler United States · #736,275 worldwide 1.8k citations · 32 works
  4. 4 David A. Basiji United States · #938,949 worldwide 1.4k citations · 20 works
  5. 5 Thaddeus C. George United States · #971,002 worldwide 3k citations · 34 works
  6. 6 Brian E. Hall United States · #1,121,891 worldwide 3.3k citations · 68 works
  7. 7 Alexander Gragerov United States · #1,177,230 worldwide 3k citations · 23 works
  8. 8 Thaddeus C. George United States · #1,207,292 worldwide 1.3k citations · 36 works
  9. 9 Sherree L. Friend United States · #1,329,118 worldwide 1.2k citations · 30 works
  10. 10 Gregory A. Demopulos United States · #1,703,812 worldwide 1.1k citations · 40 works
All ranked researchers at Omeros Corporation (United States)

What are the most cited papers from Omeros Corporation (United States)?

The most cited paper from Omeros Corporation (United States) is "Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma" (Georg Lenz et al., 2008), with 886 citations. Next come "Cellular Image Analysis and Imaging by Flow Cytometry" (427) and "Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial" (300).

Most cited papers
#PaperReleasedCitations
1 Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma Georg Lenz et al. · Science 6 Mar 2008 886
2 Cellular Image Analysis and Imaging by Flow Cytometry David A. Basiji, William E. Ortyn, Luchuan Liang et al. · Clinics in Laboratory Medicine Open access 21 Jul 2007 427
3 Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial Adam L. Boxer et al. · The Lancet Neurology Open access 26 May 2014 300
4 Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow Thaddeus C. George, Stacey L. Fanning, Patricia Fitzgeral-Bocarsly et al. · Journal of Immunological Methods 14 Mar 2006 254
5 Distinguishing modes of cell death using the ImageStream® multispectral imaging flow cytometer Thaddeus C. George, David A. Basiji, Brian E. Hall et al. · Cytometry Part A Open access 17 May 2004 251
All 60 most cited papers, with filters and sorting

Which keywords describe research at Omeros Corporation (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Innate Immunity, Inflammation, Regulation, Immunity, Cancer Immunotherapy, Complement, Immune and Genetics.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation8▲ 4.8×31 topics
  2. Innate Immunity6▲ 28×6 topics
  3. Regulation4▲ 9.9×4 topics
  4. Cancer4▲ 4.1×13 topics
  5. Immunity4▲ 17×6 topics
  6. Cancer Immunotherapy4▲ 40×3 topics
  7. Genetics4▲ 6.7×3 topics
  8. Machine Learning4▲ 2.4×5 topics
  9. Complement3▲ 235×1 topic
  10. Immune3▲ 235×1 topic
  11. Deep Learning3▲ 2.3×4 topics
  12. Gene Expression3▲ 6.3×5 topics
  13. Glycosylation3▲ 17×2 topics
  14. Image Processing3▲ 12×2 topics
  15. Monoclonal Antibodies2▲ 26×3 topics
  16. Bioimage Analysis2▲ 136×1 topic
  17. High-Content Screening2▲ 136×1 topic
  18. Dendritic Cells2▲ 29×2 topics
  19. Pharmacology2▲ 10×3 topics
  20. Reactive Oxygen Species2▲ 6.7×7 topics
  21. Therapeutic Antibodies2▲ 27×2 topics
  22. Therapeutic Targets2▲ 15×4 topics
  23. Antibody Engineering2▲ 32×1 topic
  24. Fc Receptors2▲ 32×1 topic
  25. Antigen Presentation2▲ 30×2 topics
  26. Immune Regulation2▲ 23×3 topics
  27. Stress2▲ 7.3×3 topics
  28. Toll-like Receptors2▲ 17×3 topics
  29. Tumor Antigen2▲ 37×1 topic
  30. Vaccine Adjuvants2▲ 37×1 topic
  31. Macrophages2▲ 17×2 topics
  32. CD472▲ 168×1 topic
  33. apoptotic cells2▲ 168×1 topic
  34. NK Cell Recognition2▲ 24×1 topic
  35. Natural Killer Cells2▲ 24×1 topic
  36. Pattern Recognition Receptors2▲ 16×2 topics
  37. Tumor Targeting2▲ 18×3 topics
  38. Autoimmunity2▲ 11×4 topics
  39. Glaucoma2▲ 14×2 topics
  40. Thrombosis2▲ 10×4 topics

Which research topics does Omeros Corporation (United States) publish most on?

By volume in 2022-now: Complement system in diseases, Monoclonal and Polyclonal Antibodies Research, Renal Diseases and Glomerulopathies and Renal Transplantation Outcomes and Treatments.

  1. 1 Complement system in diseases Immunology 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Renal Diseases and Glomerulopathies Nephrology 1 works
  4. 4 Renal Transplantation Outcomes and Treatments Transplantation 0 works
  5. 5 Systemic Lupus Erythematosus Research Rheumatology 0 works
  6. 6 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 0 works
  7. 7 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  8. 8 Blood groups and transfusion Hematology 0 works
  9. 9 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works
  10. 10 COVID-19 Clinical Research Studies Infectious Diseases 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.4%not open57.6%

World: 40% of research is openly available.

with international co-authors30.7%domestic only69.3%

World: 18% is written across borders.

How has Omeros Corporation (United States)'s research output changed?

Output in 2022-2025 was 1% lower than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Omeros Corporation (United States) as a percentage of every work published that year, 0.000018% in 2024.

still counting0.00020%0.00040%Omeros Corporation (United States)0.000014% in 202519801990200020102020

Fractional works of Omeros Corporation (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Seattle

All research institutions in Seattle

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Omeros Corporation (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.